These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12208971)

  • 1. Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.
    Ma J; Kennedy-Stoskopf S; Jaynes JM; Thurmond LM; Tompkins WA
    J Virol; 2002 Oct; 76(19):9952-61. PubMed ID: 12208971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity.
    Kashiwase H; Katsube T; Iida K; Komai T; Nishigaki T; Kimura T; Yamashita M
    Arch Virol; 2000; 145(5):859-69. PubMed ID: 10881674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
    Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
    J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.
    Lombardi S; Massi C; Indino E; La Rosa C; Mazzetti P; Falcone ML; Rovero P; Fissi A; Pieroni O; Bandecchi P; Esposito F; Tozzini F; Bendinelli M; Garzelli C
    Virology; 1996 Jun; 220(2):274-84. PubMed ID: 8661378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
    Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
    Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
    Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
    Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
    Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
    J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
    Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
    Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the activity of antivirals towards feline immunodeficiency virus in different cell culture systems.
    van der Meer FJ; Schuurman NM; Balzarini J; Egberink HF
    Antiviral Res; 2007 Nov; 76(2):198-201. PubMed ID: 17640744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.
    Giannecchini S; Di Fenza A; D'Ursi AM; Matteucci D; Rovero P; Bendinelli M
    J Virol; 2003 Mar; 77(6):3724-33. PubMed ID: 12610147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines.
    Baba K; Mizukoshi F; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
    Vet Microbiol; 2007 Mar; 120(3-4):207-16. PubMed ID: 17125939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G; Castelot S; Sonigo P
    Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
    Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
    J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral properties of a crude extract from a green alga Caulerpa taxifolia (Vahl) C. Agardh.
    Nicoletti E; Della Pietà F; Calderone V; Bandecchi P; Pistello M; Morelli I; Cinelli F
    Phytother Res; 1999 May; 13(3):245-7. PubMed ID: 10353170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines.
    Baba K; Goto-Koshino Y; Mizukoshi F; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
    J Vet Med Sci; 2008 Aug; 70(8):777-83. PubMed ID: 18772551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.